Coffee, hunger, and peptide yy

Journal of the American College of Nutrition

Volumn 31, Issue 3, 2012, Pages 160-166

  Greenberg, James A ^a   Geliebter, Allan ^b  

^a CITY UNIVERSITY OF NEW YORK   (United States)

^b St Luke's Roosevelt Hospital Center ^*  (United States)

Author keywords

Appetite; Caffeine; Coffee; Decaffeinated coffee; Hunger; Obesity; Peptide YY; Satiety hormones

Indexed keywords

GHRELIN; GLUCOSE; LEPTIN; PEPTIDE YY; PLACEBO; WATER;

ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; COFFEE; HUMAN; HUNGER; INGESTION; MALE; NORMAL HUMAN; NUTRITIONAL ASSESSMENT; SATIETY; VISUAL ANALOG SCALE;

ANALYSIS OF VARIANCE; AREA UNDER CURVE; BEVERAGES; CAFFEINE; COFFEE; CROSS-OVER STUDIES; GHRELIN; HUMANS; HUNGER; LEPTIN; MALE; PEPTIDE YY; SATIETY RESPONSE; SINGLE-BLIND METHOD; YOUNG ADULT;

EID: 84871762141     PISSN: 07315724     EISSN: 15411087     Source Type: Journal    
DOI: 10.1080/07315724.2012.10720023     Document Type: Article

References (27)

1. FlegalKM, CarrollMD, OgdenCL, CurtinLR: Prevalence and trends in obesity among US adults, 1999-2008. JAMA 303:235-241, 2010.
2. (NHLBI) National Heart, Lung, and Blood Institute: “Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults - The Evidence Report.”Bethesda, MD: US Department of Health and Human Services, National Institutes of Health, NIH Publication No. 98-4083, 1998.
3. BultMJ, van DalenT, MullerAF: Surgical treatment of obesity. Eur J Endocrinol158:135-145, 2008.
4. BloomSR, KuhajdaFP, LaherI, Pi-SunyerX, RonnettGV, TanTM, WeigleDS: The obesity epidemic: pharmacological challenges. Mol Interv8:82-98, 2008.
5. BrayGA, GreenwayFL: Pharmacological treatment of the overweight patient. Pharmacol Rev59:151-184, 2007.
6. LundsbergLS: Caffeine consumption. In Spiller GA (ed): “Caffeine.”Boca Raton, FL: CRC Press, pp 199-224, 1998.
7. Salazar-MartinezE, WillettWC, AscherioA, MansonJE, LeitzmannMF, StampferMJ, HuFB: Coffee consumption and risk for type 2 diabetes mellitus. Ann Intern Med140:1-8, 2004.
8. DellaliberaO, LemaireB, LafayS: Le svetol, un extrait de caf vert decafine, induit une perte de poids et augmente le ratio masse maigre sur masse grasse chez des volontaires en surcharge ponderale. Phytotherapie4:194-197, 2006.
9. ThomE: The effect of chlorogenic acid enriched coffee on glucose absorption in healthy volunteers and its effect on body mass. J Int Med Res35:900-908, 2007.
10. OnakpoyaI, TerryR, ErnstE: The use of green coffee extract as a weight loss Supplement: a systematic review and meta-analysis of randomised clinical trials. Gastroenterol Res Pract2011:1-6, 2001.
11. Lopez-GarciaE, van DamRM, RajpathakS, WillettWC, MansonJE, HuFB: Changes in caffeine intake and long-term weight change in men and women. Am J Clin Nutr83:674-680, 2006.
12. WrenAM, SmallCJ, WardHL, MurphyKG, DakinCL, TaheriS, KennedyAR, RobertsGH, MorganDG, GhateiMA, BloomSR: The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology141:4325-4328, 2000.
13. UenoH, YamaguchiH, MizutaM, NakazatoM: The role of PYY in feeding regulation. Regul Pept145:12-16, 2008.
14. SpiegelmanBM, FlierJS: Obesity and the regulation of energy balance. Cell104:531-543, 2001.
15. GavrieliA, YannakouliaM, FragopoulouE, MargaritopoulosD, ChamberlandJP, KaisariP, KavourasSA, MantzorosCS: Caffeinated coffee does not acutely affect energy intake, appetite, or inflammation but prevents serum cortisol concentrations from falling in healthy men. J Nutr141:703-707, 2011.
16. GrahamTE, HibbertE, SathasivamP: Metabolic and exercise endurance effects of coffee and caffeine ingestion. J Appl Physiol85:883-889, 1998.
17. FlintA, RabenA, BlundellJE, AstrupA: Reproducibility, power and validity of visual analogue scales in assessment of appetite sensations in single test meal studies. Int J Obesity24:38-48, 2000.
18. BatterhamRL, CowleyMA, SmallCJ, HerzogH, CohenMA, DakinCL, WrenAM, BrynesAE, LowMJ, GhateiMA, ConeRD, BloomSR: Gut hormone PYY (3-36) physiologically inhibits food intake. Nature418:650-654, 2002.
19. SilenoAP, BrandtGC, SpannBM, QuaySC: Lower mean weight after 14 days intravenous administration peptide YY3-36 (PYY3- 36) in rabbits. Int J Obes30:68-72, 2006.
20. KoeglerFH, EnrioriPJ, BillesSK, TakahashiDL, MartinMS, ClarkRL, EvansAE, GroveKL, CameronJL, CowleyMA: Peptide YY(3B36) inhibits morning, but not evening, food intake and decreases body weight in rhesus macaques. Diabetes 54:3198-3204, 2005.
21. ShimodaH, SekiE, AitaniM: Inhibitory effect of green coffee bean extract on fat accumulation and body weight gain in mice. BMC Complement Altern Med6:1-9, 2006.
22. ChoAS, JeonSM, KimMJ, YeoJ, SeoKI, ChoiMS, LeeMK: Chlorogenic acid exhibits anti-obesity property and improves lipid metabolism in high-fat diet-induced-obese mice. Food Chem Toxicol48:937-943, 2010.
23. KodaS, DateY, MurakamiN, ShimbaraT, HanadaT, ToshinaiK, NiijimaA, FuruyaM, InomataN, OsuyeK, NakazatoM: The role of the vagal nerve in peripheral PYY3-36-induced feeding reduction in rats. Endocrinology146:2369-2375, 2005.
24. ChaudhriOB, SalemV, MurphyKG, BloomSR: Gastrointestinal satiety signals. Annu Rev Physiol70:239-255, 2008.
25. JohnstonKL, CliffordMN, MorganLM: Coffee acutely modifies gastrointestinal hormone secretion and glucose tolerance in humans: glycemic effects of chlorogenic acid and caffeine. Am J Clin Nutr78:728-733, 2003.
26. MoranTH: Gut peptides in the control of food intake Int J Obes (Lond)33(suppl 1):S7-S10, 2009.
27. DouglasBR, JansenJB, ThamRT, LamersCB: Coffee stimulation of cholecystokinin release and gallbladder contraction in humans. Am J Clin Nutr52:553-556, 1990.